KB
OGN icon

Kimelman & Baird’s Organon & Co OGN Stock Holding History

Kimelman & Baird’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.09K Hold
450
– – ﹤0.01% 223
2026
Q1 		$2.7K Hold
450
– – ﹤0.01% 229
2025
Q4 		$3.23K Sell
450
-2
-0.4% -$16 ﹤0.01% 227
2025
Q3 		$4.83K Hold
452
– – ﹤0.01% 248
2025
Q2 		$4.38K Hold
452
– – ﹤0.01% 277
2025
Q1 		$6.73K Hold
452
– – ﹤0.01% 272
2024
Q4 		$6.74K Hold
452
– – ﹤0.01% 275
2024
Q3 		$8.65K Hold
452
– – ﹤0.01% 277
2024
Q2 		$9.36K Buy
+452
New +$8.98K ﹤0.01% 275
2021
Q2 		$527K Buy
+17,408
New +$573K 0.05% 79

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Kimelman & Baird's OGN Position: Q2 2026 in Review

Kimelman & Baird held its Organon & Co (OGN) position steady in Q2 2026 at 450 shares worth $6.09K. The position accounts for ﹤0.01% of the portfolio, ranked #223.

Kimelman & Baird first reported a position in OGN in Q2 2021 and has held it in 10 quarters since. The position peaked at $527K in Q2 2021. 636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Kimelman & Baird held 450 shares of Organon & Co worth $6.09K as of Q2 2026.
  • Kimelman & Baird left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Kimelman & Baird's portfolio in Q2 2026, its #223 holding.
  • Kimelman & Baird first reported a position in Organon & Co in Q2 2021 and has held it in 10 quarters since.
  • Kimelman & Baird's Organon & Co position peaked at $527K in Q2 2021.
  • 636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Kimelman & Baird's 13F filing for Q2 2026, filed 5 Aug 2026.